chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer via call center representative and described the occurrence of shingles in a male patient who received SHINGRIX for prophylaxis. On 30th December 2018, the patient received the 1st dose of SHINGRIX. On 16th January 2019, 17 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were reported as follows: This case was reported by the patient's wife. The age at vaccination was not reported. The patient broke out a day before the date of reporting yesterday (16th January 2019) and the physician confirmed that it was shingles. The reporter asked could the patient experience mild case of shingles after vaccine.
Information has been received from a pharmacist referring to a 73 years old female patient. The patient's medical history, concurrent condition and concomitant therapy were unknown. On 07-SEP-2016, the patient was vaccinated with PNEUMOVAX 23 (lot# M024673, expiration date 17-NOV-2017, dose unknown) intramuscularly. On the same day, 2 hours after the injection, the patient experienced extreme pain at the injection site with inability to lift the affected arm, and also experienced fever of 102 Fahrenheit degree (F). The patient was advised by pharmacist to take ADVIL and applied ice compresses. No lab diagnosis was performed. The outcome of the events was unknown. The causality assessment between the events and PNEUMOVAX 23 was not reported. The pharmacist was requesting a lot check of lot # M024673. This is one of several reports received from the same reporter. Additional information has been requested.
01/04/23 presents to ED for "low back pain" "shortness of breath". PMHx of "hyperlipidemia, depression, and chronic back pain"
Flu-like symptom; Arm pain; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sales representative. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on 12Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. In Jan2021, the patient experienced flu-like symptom and arm pain after receiving first dose of Pfizer COVID-19 vaccine on 12Jan2021. The outcome of the events was unknown.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.
reporting "adverse effect" from the 1st shot of the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (reporting "adverse effect" from the 1st shot of the Moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (reporting "adverse effect" from the 1st shot of the Moderna vaccine). At the time of the report, ADVERSE EVENT (reporting "adverse effect" from the 1st shot of the Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
8 days after injection: swelling, redness, hot to the touch, and  itching at the site of injection. Lasted 4 days. No other symptoms.
This spontaneous report was received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown age and gender. No concurrent or historical conditions were reported. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 (Lot # K026246, expiration date 28-JAN-2017) and (lot # L011846, expiration date 16-JUN-2017), doses, routes and anatomical locations were not provided. No concomitant medications were reported. No adverse effects reported. No product quality complaint involved. This is one of several reports received from the same source. Additional information has been requested.
received vaccine 6 years ago, only received one dose; shingles; This case was reported by a nurse via call center representative and described the occurrence of shingles in a 66-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. In July 2022, more than 2 years after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 21-Jun-2022 Reporter's comment: The reporter was the patient, who received a shingles vaccine about 6 years ago.  She did not know which shingles vaccine it was (Zostavax or Shingrix).  She stated that this past month she had an episode of shingles.  She had also only received one dose of the shingles vaccine.  The consent to follow up was granted.
I experienced severe headache, fever of 101, chills and excruciating hip pain that lasted for 48 hours.The hip pain was so severe that it prevented me from putting weight on my foot to walk.
A few minutes after immunization, patient felt dizzy and faint and increase heart rate. She said while I was giving the vaccine that she is terrified of needles. She seemed ok, like panic attack. Her husband, was with her, who also received his second Covid vaccine. She said she was ok. I told her to check back in a little while. Her blood pressure was checked and WNL. SHe felt good when she left the pharmacy. I asked her to please call me later that day (yesterday) to let me know how she felt  (has not yet) and to go to ER if she began to feel worse, I have not been able to reach as of yet.
Patient stated that she experienced headaches, muscle and joint aches, chills, sweating, fever, and a sore arm. Patient stated that she took 2 pills of Tylenol (strength unknown) and that symptoms resolved within a day.
1.5 weeks after the vaccination, my skin all over my body began to be severely itchy and has continued since. When scratching, my skin quickly turns red. This is consistent with my reaction to the Moderna COVID-19 booster taken last year, on 10/31/2021. I had 2.5 months of severe itching and then, it slowly subsided. Last year, I did not take my flu shot with my COVID booster as I did this year. For my current reaction, Zyrtec was suggested by my dermatologist to lessen the effects.  Also, possibly unrelated to the booster: - Increased heart palpitations - Dizziness; off-balanced
This was my "booster" vaccine, administered 2 months and 5 days after the initial vaccine (Aug. 2, 2019). I did not experience any issues then, other than soreness at the injection site.  At 2 a.m. Oct. 8, 11 hours after the injection (3 p.m., Oct. 7), I awoke with an upset stomach, raging headache, and all-over body aches. I also felt hot. Took my temperature and it was 101 degrees F.  Cheeks were flushed. I took 600 mg of Advil to help with the aches and fever (Acetaminophen does not help me with body aches.).  Fever resolved approximately 6 hours after onset. 24 hours after vaccine, I still have a slight headache and upset stomach and slight body aches.
Anti-HBs Antibody Negative; This spontaneous report was received from a registered nurse referring to an approximately 20 year old female patient. The patient pertinent medical history, concurrent conditions, concomitant therapies and past drug reactions/allergies were not reported.    On an unknown date, when the patient was 19 or younger, she was vaccinated with a dose of hepatitis b vaccine (recombinant)(RECOMBIVAX HB) 5/0.5 micrograms/milliliters; 0.5 milliliters, intramuscular (anatomical location, lot # and expiration date were not provided) for immunisation.  On an unknown date in 2020,  the patient had her titres drawn which came back negatives (hepatitis b surface antibody negative). No product quality complaints were reported.  At the time of the report, the outcome of the event hepatitis b surface antibody negative was reported as not recovered.  The reporter did not assess a causal relationship between the event hepatitis b surface antibody negative and hepatitis b vaccine (recombinant)(RECOMBIVAX HB).
Chills; Fatigue; Muscle soreness; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 13Apr2021 at 14:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included asthma, scoliosis and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), sertraline (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN) and salbutamol (ALBUTEROL); all from unknown dates for unspecified indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 23Mar2021 at 14:15 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. It was unknown whether the patient received any other vaccines within four weeks prior to the COVID-19 vaccination. On 14Apr2021 at 07:00, the patient experienced the events chills, fatigue, muscle soreness and weakness. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of adverse events. The clinical outcome of the events chills, fatigue, muscle soreness and weakness were not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
Contracted Covid-19.  Symptoms appeared 4/9/22: mild cough, fatigue.  Symptoms persisted for several days without fever or increasing severity.  Tested via rapid test on 4/11 - positive result.  Family members also developed symptoms following days.
Fever, muscle aches, extreme back pain, nausea.  Fever lasted one day;  muscle aches & back pain lasted 3 days.  Nausea lasted 3 days, but indigestion lasted 5 days.  On day two I went for a short walk and it felt like there was a brick on my chest...I could breathe ok, but heavy feeling in my back and chest.   I walked on day 3 with no issues.  I also developed 4-5  hives on my stomach on day three which were gone on day 4. I took tylenol for the fever and aches after talking with the nurse at my doctors office. After speaking with a few female friends who had the same vaccine, they experienced similar side effects, however their husbands who received the same shot had no issues.  I am wondering if the shot is affecting women differently.
A while after receiving Prevnar 13 on 09-25-15, patient experienced uncontrollable shaking of both of her fore arms.  She also experienced a flushed face, bubbly, peeling lips, and dizziness.  She needed assistance walking due to the dizziness.  On 09-26-15 patient felt aches, chills, fatigue, and lack of appetite, and some dizziness.  Patient no longer had uncontrollable fore arm shaking or bubbly peeling lips or flushed face.  Patient has not sought treatment.  She reported her experience to me on 09-26-15.
Patient tested positive for COVID 4/14/21. Completed COVID vaccine series 1/26/21. Onset of symptoms 4/7/21.
pt had gen sz 27-28hr p/vax;sz lasted 5-10min p/which pt is doing fine;
Between 03/04/2021 and 09/30/22 I had 7 vaccinations in my left shoulder -- 5 Covid vaccinations and 2 Shingles vaccinations.  After the second of the shingles vaccination (the fifth vaccination overall), I developed severe, excruciating pain in my left shoulder. That vaccine was 3/24/2022; I went to the emergency room in 3/28/2022 with 10/10 pain. This pain event lasted about 8 hours and was diagnosed as "Trapezius Strain."  I subsequently had two more Covid boosters in the same shoulder, followed by more severe shoulder pain events. In 2023, the pain has now become chronic and debilitating.  I don't know if this pain is related to the vaccines or not -- that is why I am reporting it. History of vaccinations in left shoulder, and the development of severe left shoulder pain:  3/4/21 Covid Moderna  4/1/21 Covid Moderna 10/22/21 Covid Booster Moderna 12/7/21 Zoster Shingrex 3/24/22 Zoster Shingrex  (First Pain Event becomes severe 3/28/21 -- ER visit) 5/19/22 Covid Booster Moderna (Intermittent severe left shoulder pain events 10/10 pain) 9/30/22 Covid Booster Pfizer (Intermittent severe left shoulder pain events, 10/10 pain) 2023 (Severe left shoulder pain become chronic. Pain becomes debilitating several times per week.)
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: and testing positive again. Therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
3/4/21  first dose of moderna vaccine 3/11/21 one week after vaccine - begin with significant persistent abdominal pain and headaches 4/1/21 second dose of moderna vaccine 4/13/21 less than two weeks after vaccine significant wheezing  4/14/21 Ultrasound of abdomen 4/15/21 MRI of abdomen 4/21/21 xray of lung 4/23/21 CT of lungs 4/24/21 Biopsy of pancreas (revealed small cell cancer)   4/25/21 admitted for pancreatitis (caused by biopsy procedure) 5/3/21 face drooping on one side (brain CT revealed mass on brain) 5/10/21 passed away  In the hospital there were numerous CTs, Xrays, and Ultrasounds for various reasons. Cancer was found on the pancreas, lungs, bone, brain.  While I am not convinced that the vaccine caused the cancer, I am definitely not ruling it out.  I am convinced that the vaccine prohibited the body's natural response to fight the cancer or it caused it to "flare up" or "ignited it".   Patient was a healthy active man until he received the vaccine. Then suddenly one week later he had pain in his abdomen and head and had trouble breathing. Then within two months he is deceased.  The probability of having cancer show symptoms in three places suddenly at the same time seems extremely unlikely unless something triggered it.  While patient was a proponent of getting the vaccine, after getting it he repeatedly said that it made him sick.  Does data show a rise in cancer statistics (diagnosis and deaths) since Covid vaccines were administered?
Tired- Headache- soarness arm- Low grade fever 99.8 (all 9:00 pm) (12-30-2021)
My grandson suffered a massive heart attack, septic, organ failure and passed March 10th 2022 leaving 2 babies fatherless
TWO ADVERSE REACTIONS: 1. My period is practically non-existent. I barely bleed! What happened to my ovaries??? Am  I still going to be able to have children in the future? My period has changed dramatically since getting vaccinated in May 2021 and 2nd dose in June 2021. I had a regular menstrual cycle in the past, a regular flow, and healthy and normal period. Now I hardly bleed and it greatly concerns me.  2. I don't have any heart disease in my family. I am now 38 and have an enlarged right part of my heart along with irregular heart beats - myocarditis.
Covid arm- severe pain at injection site, large red rash is both painful and itchy.  It started about 8 hours after receiving dose and got worse over the next 24 hours.  Rash is still present on day 3 after injection.
Delayed the 2nd dose until 09May2021; crazy itching; bad rash on body,bad rash on head,bad rash on chest,bad rash on waist,bad rash on arms,bad rash on back, bad rash on body; bad rash on leg; cannot sleep; red dots on roof of her mouth; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (crazy itching), RASH (bad rash on body,bad rash on head,bad rash on chest,bad rash on waist,bad rash on arms,bad rash on back, bad rash on body), RASH (bad rash on leg), INSOMNIA (cannot sleep) and ORAL MUCOSAL ERYTHEMA (red dots on roof of her mouth) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Milk allergy, Food allergy (codfish) and Food allergy (Had a small rash on wrist, didn't think anything of it.) since 03-Mar-2021.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PRURITUS (crazy itching), RASH (bad rash on body,bad rash on head,bad rash on chest,bad rash on waist,bad rash on arms,bad rash on back, bad rash on body), RASH (bad rash on leg), INSOMNIA (cannot sleep) and ORAL MUCOSAL ERYTHEMA (red dots on roof of her mouth). On 23-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Delayed the 2nd dose until 09May2021). At the time of the report, PRURITUS (crazy itching), RASH (bad rash on body,bad rash on head,bad rash on chest,bad rash on waist,bad rash on arms,bad rash on back, bad rash on body), RASH (bad rash on leg), INSOMNIA (cannot sleep), ORAL MUCOSAL ERYTHEMA (red dots on roof of her mouth) and PRODUCT DOSE OMISSION ISSUE (Delayed the 2nd dose until 09May2021) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided
Information has been received from a registered nurse concerning an 8 week old female with no pertinent medical history or drug allergies who on 08-MAY-2008 was vaccinated PO with a dose of ROTATEQ (lot# 660201/0142X) and experienced projectile vomiting upon administration. The patient sought medical attention in the physician's office. It was noted that family members of the child had been sick recently. The outcome was unknown. There was no product quality complaint. Follow-up information from the reporting administering registered nurse indicated that the 8 week old (11lb, 5oz., 23in.) white female who on 07-MAY-2008 at 15:30 (also reported as 08-MAY-2008) was vaccinated PO with her first dose of ROTATEQ (lot# 660201/0142X). There was no concomitant medication. At the time of vaccination the patient's family members were noted to have an intestinal virus including vomiting. On 07-MAY-2008 at 15:30 (also reported as 08-MAY-2008) the patient vomited a large amount of fluid while the vaccine was administered. Approximately 3/4 viral was given; the rest was discharged due to stomach upset. The doctor did not want the patient  to get the rest of the dose. No labs or diagnostic studies were performed. Additional information has been requested.
Achy body, tingling sensation from armpit to forearm. Forearm warm to the touch.
Patient came over to pharmacy next day and said 3 hrs after FLUVIRIN vaccine given, she experienced sweating, diarrhea, pain in her chest area. She doesn't know if reaction is from vaccine or heartburn. She has not taken her heartburn med since June. She said her symptoms have improved. Followed up with patient 9/19/12 patient had no more symptoms.
Patient reported sore neck after administration of FLUZONE HD, ZOSTAVAX and PREVENAR 13.
Extremely tired back muscles; body heat; felt unstable; lost a lot of sleep; could not lay prone; This is a spontaneous report from a contactable consumer. The consumer reported similar events for 2 patients (gal and another person). This is second of two reports. This consumer reported for another patient that. A patient of unspecified age and gender received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that there was a call from the caller who said that she knows it was experimental she did had a reaction and others did as well. She said that she had extremely tired back muscles and body heat. While reporting on herself, the caller mentioned that another gal had the same thing and another person she knew had the same thing. She also mentioned that felt unstable, lost a lot of sleep, could not lay prone on unspecified date. Outcome of all events was unknown.   Follow-up attempts completed. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021178927 same reporter, different patient
Patient received the Pediarix instead of the Dtap- Infanrix; Patient received a fourth dose of Pediarix / 4 doses of the Hep-b; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 12-month-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number K7TF9, expiry date unknown) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 15th July 2020, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On 15th July 2020, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and extra dose administered. On an unknown date, the outcome of the wrong vaccine administered and extra dose administered were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter stated that, the patient received  Pediarix instead of the Dtap- Infanrix, which led to wrong vaccine administered. The patient received 4the dose of Pediarix, which led to extra dose administered of hepatitis B component. No reactions reported. The reporter consented to follow up.
Patient presented the following day reporting a "PTSD episode triggered by the vaccine." She is now seeking assistance for the physical effects of a "cortisol dump," but refuses the suggestion of the ER or Urgent Care as they will lock her up and tell her she is crazy. She does not have a PCP.  At the time of the vaccine patient was fine- in no apparent distress. She was monitored for 30 minutes after and just reported tingling in her fingers. She reported it was not from the shot in her arm when it was suggested. "When this happens she gets up and walks around."  She  was offered a glass of water and accepted. She drank the glass of water and communicated no distress. It was only the following day that she reported this vaccine triggered a PTSD event, but would not elaborate.